1. Executive Summary
1. Market Overview
1. Market Landscape
1. Market ecosystem
2. Value chain analysis
1. Market Sizing
1. Market definition
2. Market segment analysis
3. Market size 2019
4. Market outlook: Forecast for 2019 – 2024
1. Five Forces Analysis
1. Five Forces Summary
2. Bargaining power of buyers
3. Bargaining power of suppliers
4. Threat of new entrants
5. Threat of substitutes
6. Threat of rivalry
7. Market condition
1. Market Segmentation by End-user
1. Market segments
2. Comparison by End user placement
3. Pharma and biotech companies – Market size and forecast 2019-2024
4. Academic and research institutes – Market size and forecast 2019-2024
5. CROs – Market size and forecast 2019-2024
6. Market opportunity by End user
1. Customer landscape
1. Overview
1. Geographic Landscape
1. Geographic segmentation
2. Geographic comparison
3. North America – Market size and forecast 2019-2024
4. Europe – Market size and forecast 2019-2024
5. APAC – Market size and forecast 2019-2024
6. South America – Market size and forecast 2019-2024
7. MEA – Market size and forecast 2019-2024
8. Key leading countries
9. Market opportunity by geography
1. Drivers, Challenges, and Trends
1. Market drivers
2. Volume driver – Demand led growth
3. Volume driver – Supply led growth
4. Volume driver – External factors
5. Volume driver – Demand shift in adjacent markets
6. Price driver – Inflation
7. Price driver – Shift from lower to higher priced units
8. Market challenges
9. Market trends
1. Vendor Landscape
1. Overview
2. Vendor landscape
3. Landscape disruption
1. Vendor Analysis
1. Vendors covered
2. Market positioning of vendors
3. BEX Co. Ltd.
4. Bio-Rad Laboratories Inc.
5. Celetrix LLC
6. Cellectricon AB
7. Eppendorf AG
8. Harvard Bioscience Inc.
9. Lonza Group Ltd.
10. MaxCyte Inc.
11. Merck KGaA
12. Thermo Fisher Scientific Inc.
1. Appendix
1. Scope of the report
2. Currency conversion rates for US$
3. Research methodology
4. List of abbreviations
Exhibits
1.Key Finding 1
2.Key Finding 2
3.Key Finding 3
4.Key Finding 4
5.Key Finding 5
6.Key Finding 6
7.Key Finding 7
8.Market in focus
9.Parent market
10.Market characteristics
11.Product / Service portfolio of key vendors included in the market definition
12.Market segments
13.Global – Market size and forecast 2019 – 2024 ($ million)
14.Global market: Year-over-year growth 2019 – 2024 (%)
15.Five forces analysis 2019 & 2024
16.Bargaining power of buyers
17.Bargaining power of suppliers
18.Threat of new entrants
19.Threat of substitutes
20.Threat of rivalry
21.Market condition – Five forces 2019
22.End user placement – Market share 2019-2024 (%)
23.Comparison by End user placement
24.Pharma and biotech companies – Market size and forecast 2019-2024 ($ million)
25.Pharma and biotech companies – Year-over-year growth 2019-2024 (%)
26.Academic and research institutes – Market size and forecast 2019-2024 ($ million)
27.Academic and research institutes – Year-over-year growth 2019-2024 (%)
28.CROs – Market size and forecast 2019-2024 ($ million)
29.CROs – Year-over-year growth 2019-2024 (%)
30. Market opportunity by End user
31.Customer landscape
32.Market share by geography 2019-2024 (%)
33.Geographic comparison
34.North America – Market size and forecast 2019-2024 ($ million)
35.North America – Year-over-year growth 2019-2024 (%)
36.Europe – Market size and forecast 2019-2024 ($ million)
37.Europe – Year-over-year growth 2019-2024 (%)
38.APAC – Market size and forecast 2019-2024 ($ million)
39.APAC – Year-over-year growth 2019-2024 (%)
40.South America – Market size and forecast 2019-2024 ($ million)
41.South America – Year-over-year growth 2019-2024 (%)
42.MEA – Market size and forecast 2019-2024 ($ million)
43.MEA – Year-over-year growth 2019-2024 (%)
44.Key leading countries
45.Market opportunity by geography ($ million)
46.Impact of drivers
47.Impact of challenges
48.Landscape disruption
49.Industry risks
50.Vendors covered
51.Market positioning of vendors
52.BEX Co. Ltd. – Overview (1/3)
53.BEX Co. Ltd. – Overview (2/3)
54.BEX Co. Ltd. – Overview (3/3)
55.BEX Co. Ltd. – Product and service
56.BEX Co. Ltd. – Key offerings
57.BEX Co. Ltd. – Key customers
58.BEX Co. Ltd. – Segment focus
59.Bio-Rad Laboratories Inc. – Overview (1/3)
60.Bio-Rad Laboratories Inc. – Overview (2/3)
61.Bio-Rad Laboratories Inc. – Overview (3/3)
62.Bio-Rad Laboratories Inc. – Business segments
63.Bio-Rad Laboratories Inc. – Key offerings
64.Bio-Rad Laboratories Inc. – Key customers
65.Bio-Rad Laboratories Inc. – Segment focus
66.Celetrix LLC – Overview (1/3)
67.Celetrix LLC – Overview (2/3)
68.Celetrix LLC – Overview (3/3)
69.Celetrix LLC – Product and service
70.Celetrix LLC – Key offerings
71.Celetrix LLC – Key customers
72.Celetrix LLC – Segment focus
73.Cellectricon AB – Overview (1/3)
74.Cellectricon AB – Overview (2/3)
75.Cellectricon AB – Overview (3/3)
76.Cellectricon AB – Product and service
77.Cellectricon AB – Key offerings
78.Cellectricon AB – Key customers
79.Cellectricon AB – Segment focus
80.Eppendorf AG – Overview (1/3)
81.Eppendorf AG – Overview (2/3)
82.Eppendorf AG – Overview (3/3)
83.Eppendorf AG – Product and service
84.Eppendorf AG – Key offerings
85.Eppendorf AG – Key customers
86.Eppendorf AG – Segment focus
87.Harvard Bioscience Inc. – Overview (1/3)
88.Harvard Bioscience Inc. – Overview (2/3)
89.Harvard Bioscience Inc. – Overview (3/3)
90.Harvard Bioscience Inc. – Business segments
91.Harvard Bioscience Inc. – Key offerings
92.Harvard Bioscience Inc. – Key customers
93.Harvard Bioscience Inc. – Segment focus
94.Lonza Group Ltd. – Overview (1/3)
95.Lonza Group Ltd. – Overview (2/3)
96.Lonza Group Ltd. – Overview (3/3)
97.Lonza Group Ltd. – Business segments
98.Lonza Group Ltd. – Key offerings
99.Lonza Group Ltd. – Key customers
100.Lonza Group Ltd. – Segment focus
101.MaxCyte Inc. – Overview (1/3)
102.MaxCyte Inc. – Overview (2/3)
103.MaxCyte Inc. – Overview (3/3)
104.MaxCyte Inc. – Business segments
105.MaxCyte Inc. – Key offerings
106.MaxCyte Inc. – Key customers
107.MaxCyte Inc. – Segment focus
108.Merck KGaA – Overview (1/3)
109.Merck KGaA – Overview (2/3)
110.Merck KGaA – Overview (3/3)
111.Merck KGaA – Business segments
112.Merck KGaA – Key offerings
113.Merck KGaA – Key customers
114.Merck KGaA – Segment focus
115.Thermo Fisher Scientific Inc. – Overview (1/3)
116.Thermo Fisher Scientific Inc. – Overview (2/3)
117.Thermo Fisher Scientific Inc. – Overview (3/3)
118.Thermo Fisher Scientific Inc. – Business segments
119.Thermo Fisher Scientific Inc. – Key offerings
120.Thermo Fisher Scientific Inc. – Key customers
121.Thermo Fisher Scientific Inc. – Segment focus
122.Currency conversion rates for US$
123.Research Methodology
124.Validation techniques employed for market sizing
125.Information sources
126.List of abbreviations
